Source: Environmental Toxicology. Unidade: FMVZ
Subjects: FÍGADO GORDUROSO, ANTINEOPLÁSICOS, INFLAMAÇÃO
ABNT
ROMUALDO, Guilherme Ribeiro et al. Sorafenib reduces steatosis-induced fibrogenesis in a human 3D co-culture model of non-alcoholic fatty liver disease. Environmental Toxicology, v. 36, n. 2, p. 168-176, 2021Tradução . . Disponível em: https://doi.org/10.1002/tox.23021. Acesso em: 01 out. 2024.APA
Romualdo, G. R., Silva, T. C. da, Landi, M. F. de A., Morais, J. A., Barbisan, L. F., Vinken, M., et al. (2021). Sorafenib reduces steatosis-induced fibrogenesis in a human 3D co-culture model of non-alcoholic fatty liver disease. Environmental Toxicology, 36( 2), 168-176. doi:10.1002/tox.23021NLM
Romualdo GR, Silva TC da, Landi MF de A, Morais JA, Barbisan LF, Vinken M, Oliveira CP, Cogliati B. Sorafenib reduces steatosis-induced fibrogenesis in a human 3D co-culture model of non-alcoholic fatty liver disease [Internet]. Environmental Toxicology. 2021 ; 36( 2): 168-176.[citado 2024 out. 01 ] Available from: https://doi.org/10.1002/tox.23021Vancouver
Romualdo GR, Silva TC da, Landi MF de A, Morais JA, Barbisan LF, Vinken M, Oliveira CP, Cogliati B. Sorafenib reduces steatosis-induced fibrogenesis in a human 3D co-culture model of non-alcoholic fatty liver disease [Internet]. Environmental Toxicology. 2021 ; 36( 2): 168-176.[citado 2024 out. 01 ] Available from: https://doi.org/10.1002/tox.23021